Year-end Sale % OFF 
Abstract
Lupus nephritis (LN)is classified histologically according to the International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification. Within this classification class III and IV LN have the worst prognosis and warrant intense immunosuppression with potential for more severe adverse effects. . The first line treatment for class III and IV LN in our setting is low-dose intravenous cyclophosphamide as per the Eurolupus protocol(CYC). The purpose of this study was to identify clinicopathological features at presentation which would correlate with response to treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
